COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #56
Source   PDF   Share   Tweet
See all 182 studies
Pre-Exposure Prophylaxis study (treated before exposed to the virus)
Huang et al., Annals of the Rheumatic Diseases 2020:79, 1163-1169, doi:10.1136/annrheumdis-2020-217425 (Peer Reviewed)
Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study
Analysis of 1255 COVID-19 patients in Wuhan Tongji Hospital finding 0.61% with systemic autoimmune diseases, much lower than authors expected (3%–10%). Authors hypothesise that protective factors, such as C Q/HC Q use, reduce hospitalization.
hospitalization, ↓80.0%, p<0.001
Source   PDF   Share   Tweet
See all 182 studies
Please send us corrections, updates, or comments.